Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 545

1.

Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.

O'Shaughnessy J, Petrakova K, Sonke GS, Conte P, Arteaga CL, Cameron DA, Hart LL, Villanueva C, Jakobsen E, Beck JT, Lindquist D, Souami F, Mondal S, Germa C, Hortobagyi GN.

Breast Cancer Res Treat. 2017 Nov 21. doi: 10.1007/s10549-017-4518-8. [Epub ahead of print]

PMID:
29164421
2.

Double inlay plus ventral onlay buccal mucosa graft for simultaneous penile and bulbar urethral stricture.

Favorito LA, Conte PP, Sobrinho UG, Martins RG, Accioly T.

Int Braz J Urol. 2017 Nov 17;43. doi: 10.1590/S1677-5538.IBJU.2017.0067. [Epub ahead of print]

PMID:
29135409
3.

First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer.

Dieci MV, Guarneri V, Giarratano T, Mion M, Tortora G, De Rossi C, Gori S, Oliani C, Merlini L, Pasini F, Bonciarelli G, Griguolo G, Orvieto E, Michieletto S, Saibene T, Del Bianco P, De Salvo GL, Conte P.

Oncologist. 2017 Nov 13. pii: theoncologist.2017-0322. doi: 10.1634/theoncologist.2017-0322. [Epub ahead of print]

PMID:
29133514
4.

Microstructural and associated chemical changes during the composting of a high temperature biochar: Mechanisms for nitrate, phosphate and other nutrient retention and release.

Joseph S, Kammann CI, Shepherd JG, Conte P, Schmidt HP, Hagemann N, Rich AM, Marjo CE, Allen J, Munroe P, Mitchell DRG, Donne S, Spokas K, Graber ER.

Sci Total Environ. 2017 Nov 7. pii: S0048-9697(17)32551-2. doi: 10.1016/j.scitotenv.2017.09.200. [Epub ahead of print]

PMID:
29126641
5.

Evaluation of a short formation on the performance of point-of-care renal ultrasound performed by physicians without previous ultrasound skills: prospective observational study.

Javaudin F, Mounier F, Pes P, Arnaudet I, Vignaud F, Frampas E, Le Conte P; Winfocus-France study group.

Crit Ultrasound J. 2017 Nov 9;9(1):23. doi: 10.1186/s13089-017-0078-8.

6.

External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.

Griguolo G, Jacot W, Kantelhardt E, Dieci MV, Bourgier C, Thomssen C, Bailleux C, Miglietta F, Braccini AL, Conte P, Ferrero JM, Guarneri V, Darlix A.

Breast. 2017 Oct 23;37:36-41. doi: 10.1016/j.breast.2017.10.006. [Epub ahead of print]

PMID:
29073498
7.

Combination immunotherapy strategies in advanced non-small cell lung cancer (NSCLC): Does biological rationale meet clinical needs?

Attili I, Passaro A, Pavan A, Conte P, De Marinis F, Bonanno L.

Crit Rev Oncol Hematol. 2017 Nov;119:30-39. doi: 10.1016/j.critrevonc.2017.09.007. Epub 2017 Sep 19. Review.

PMID:
29065983
8.

Organic coating on biochar explains its nutrient retention and stimulation of soil fertility.

Hagemann N, Joseph S, Schmidt HP, Kammann CI, Harter J, Borch T, Young RB, Varga K, Taherymoosavi S, Elliott KW, McKenna A, Albu M, Mayrhofer C, Obst M, Conte P, Dieguez-Alonso A, Orsetti S, Subdiaga E, Behrens S, Kappler A.

Nat Commun. 2017 Oct 20;8(1):1089. doi: 10.1038/s41467-017-01123-0.

9.

Chemotherapy for advanced HER2-negative breast cancer: Can one algorithm fit all?

Miglietta F, Dieci MV, Griguolo G, Guarneri V, Conte PF.

Cancer Treat Rev. 2017 Nov;60:100-108. doi: 10.1016/j.ctrv.2017.09.001. Epub 2017 Sep 15. Review.

PMID:
28942029
10.

Recognition and treatment of severe sepsis in the emergency department: retrospective study in two French teaching hospitals.

Le Conte P, Thibergien S, Obellianne JB, Montassier E, Potel G, Roy PM, Batard E.

BMC Emerg Med. 2017 Aug 30;17(1):27. doi: 10.1186/s12873-017-0133-6.

11.

The European Cancer Patient's Bill of Rights, update and implementation 2016.

Højgaard L, Löwenberg B, Selby P, Lawler M, Banks I, Law K, Albreht T, Armand JP, Barbacid M, Barzach M, Bergh J, Cameron D, Conte P, de Braud F, de Gramont A, De Lorenzo F, Diehl V, Diler S, Erdem S, Geissler J, Gore-Booth J, Henning G, Horgan D, Jassem J, Johnson P, Kaasa S, Kapitein P, Karjalainen S, Kelly J, Kienesberger A, La Vecchia C, Lacombe D, Lindahl T, Luzzatto L, Malby R, Mastris K, Meunier F, Murphy M, Naredi P, Nurse P, Oliver K, Pearce J, Pelouchov J, Piccart M, Pinedo B, Spurrier-Bernard G, Sullivan R, Tabernero J, Van de Velde C, van Herk B, Vedsted P, Waldmann A, Weller D, Wilking N, Wilson R, Yared W, Zielinski C, Zur Hausen H, Le Chevalier T, Johnston P.

ESMO Open. 2017 Jan 6;1(6):e000127. doi: 10.1136/esmoopen-2016-000127. eCollection 2016. Review.

12.

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Kim SB, Dent R, Im SA, Espié M, Blau S, Tan AR, Isakoff SJ, Oliveira M, Saura C, Wongchenko MJ, Kapp AV, Chan WY, Singel SM, Maslyar DJ, Baselga J; LOTUS investigators.

Lancet Oncol. 2017 Oct;18(10):1360-1372. doi: 10.1016/S1470-2045(17)30450-3. Epub 2017 Aug 8.

PMID:
28800861
13.

Biochar based remediation of water and soil contaminated by phenanthrene and pentachlorophenol.

Rao MA, Di Rauso Simeone G, Scelza R, Conte P.

Chemosphere. 2017 Nov;186:193-201. doi: 10.1016/j.chemosphere.2017.07.125. Epub 2017 Jul 26.

PMID:
28778017
14.

Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung Cancer.

Banna GL, Parra HJS, Castaing M, Dieci MV, Anile G, Nicolosi M, Strano S, Marletta F, Guarneri V, Conte P, Lal R.

Anticancer Res. 2017 Jul;37(7):3723-3728.

PMID:
28668866
15.

Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation.

Carbognin L, Sperduti I, Fabi A, Dieci MV, Kadrija D, Griguolo G, Pilotto S, Guarneri V, Zampiva I, Brunelli M, Orvieto E, Nortilli R, Fiorio E, Parolin V, Manfrin E, Caliò A, Nisticò C, Pellini F, Scarpa A, Pollini GP, Conte P, Tortora G, Bria E.

Breast. 2017 Oct;35:21-26. doi: 10.1016/j.breast.2017.06.005. Epub 2017 Jun 17.

PMID:
28628772
16.

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.

Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, Delaloge S, Li W, Tung N, Armstrong A, Wu W, Goessl C, Runswick S, Conte P.

N Engl J Med. 2017 Aug 10;377(6):523-533. doi: 10.1056/NEJMoa1706450. Epub 2017 Jun 4. Erratum in: N Engl J Med. 2017 Oct 26;377(17 ):1700.

PMID:
28578601
17.

Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists.

Urso L, Cavallari I, Silic-Benussi M, Biasini L, Zago G, Calabrese F, Conte PF, Ciminale V, Pasello G.

Oncotarget. 2017 Jul 4;8(27):44232-44241. doi: 10.18632/oncotarget.17790.

18.

Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations.

Frega S, Lorenzi M, Fassan M, Indraccolo S, Calabrese F, Favaretto A, Bonanno L, Polo V, Zago G, Lunardi F, Attili I, Pavan A, Rugge M, Guarneri V, Conte P, Pasello G.

Oncotarget. 2017 May 16;8(20):32626-32638. doi: 10.18632/oncotarget.15945.

19.

GD2 expression in breast cancer.

Orsi G, Barbolini M, Ficarra G, Tazzioli G, Manni P, Petrachi T, Mastrolia I, Orvieto E, Spano C, Prapa M, Kaleci S, D'Amico R, Guarneri V, Dieci MV, Cascinu S, Conte P, Piacentini F, Dominici M.

Oncotarget. 2017 May 9;8(19):31592-31600. doi: 10.18632/oncotarget.16363.

20.

A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study).

Gelsomino F, Bertolini F, Luppi G, Spallanzani A, Pettorelli E, Reggiani Bonetti L, Meduri B, Manco G, Conte P, Cascinu S.

Clin Colorectal Cancer. 2017 Dec;16(4):410-415.e1. doi: 10.1016/j.clcc.2017.03.011. Epub 2017 Mar 24.

PMID:
28410832

Supplemental Content

Loading ...
Support Center